We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ELYM market cap is 342.68M. The company's latest EPS is USD -0.5237 and P/E is -9.76.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.71M | -5M | -5.12M | -3.01M | -56.37M |
| Net Income | -5.22M | -3.97M | -3.64M | -1.7M | -54.89M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -35.67M | -45.14M | -40.28M |
| Net Income | -52.03M | -45.24M | -35.12M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 116.27M | 112.74M | 110.47M | 109.33M | 226.02M |
| Total Liabilities | 3.77M | 2.99M | 2.87M | 2.95M | 3.74M |
| Total Equity | 112.5M | 109.74M | 107.6M | 106.38M | 222.28M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 173.24M | 134.99M | 110.47M |
| Total Liabilities | 6.04M | 6.28M | 2.87M |
| Total Equity | 167.2M | 128.72M | 107.6M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -23.14M | -19.65M | -20.6M | -1.82M | -2.49M |
| Investing | 4.2M | 32.23M | 68.98M | 13.75M | 4.11M |
| Financing | 25k | 553k | 841k | 15k | 128.42M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36.07M | -37.37M | -20.6M |
| Investing | -114.97M | 34.44M | 68.98M |
| Financing | 177.23M | N/A | 841k |
| Market Cap | 342.68M |
| Price to Earnings Ratio | -9.76 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.68 |
| Price to Book Ratio | 3.18 |
| Dividend Yield | - |
| Shares Outstanding | 67.06M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 99.22% |
| 52 Week High | 11.55 |
| 52 Week Low | 2.35 |
| Spread (Intraday) | 0.4 (7.55%) |
| Company Name | Eliem Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://climbbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
